시간 외 거래: 11.20 0.19 +1.73%

다이나백스 테크놀로지스 (DVAX)

Dynavax Technologies Corp. 주식(DVAX)의 최신 뉴스

다이나백스 테크놀로지스 (DVAX)

Dynavax Technologies Corp. 주식(DVAX)의 최신 뉴스

Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates

Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript

Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4

Why Vera Therapeutics Stock Soared by 22% This Week

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong

Axsome (AXSM) Stock Rises on Stellar Q4 Preliminary Results

Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why

Collegium (COLL) Shares Rise on Financial Outlook for 2024

Voyager (VYGR) Gains on Gene Therapy Deal With Novartis

C4 Therapeutics (CCCC) Gains 310% in 3 Months: Here's Why

BEAM Stock Rallies More Than 25% in 3 Months: What Next?

The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

Roche (RHHBY) to Acquire LumiraDx's Point of Care Technology

Bayer (BAYRY) Loses 28% in 2023: What to Expect in 2024?

20 favorite small-cap stocks for 2024 among Wall Street analysts

Mirum (MIRM) Down on Failure of Mid-Stage Study on Livmarli

Bristol Myers (BMY) Stops Late-Stage Colorectal Cancer Study

3 Biotech Stocks Most Wall Street Analysts Are Bullish About

Gilead (GILD) Outperforms Industry in 6 Months: What Lies Ahead?

NextCure (NXTC) Down on Shelving Plans to Develop Candidate

Vertex (VRTX) Hits Record High on Non-Opioid Pain Drug Data

Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?

Regeneron (REGN) Posts Positive Data on Blood Cancer Candidate

Novartis (NVS) Gets FDA Nod for Rare Blood Disorder Drug

Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III

Can Dynavax Technologies (DVAX) Climb 91.59% to Reach the Level Wall Street Analysts Expect?

bluebird bio (BLUE) Stock Gains 25.6% in a Month: Here's How

Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?

Avidity (RNA) Expands Collaboration With BMY, Shares Rise

Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy

Tharimmune (THAR) Up on Positive Data From Pipeline Candidate

Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How

Is Dynavax Technologies (DVAX) Stock Outpacing Its Medical Peers This Year?

Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals

Eli Lilly (LLY) Stock Outperforms Industry YTD: Here's Why

Merck (MRK) to Acquire Private Neuroscience Company for $610M

5 Biotech Stocks Likely to Thrive as Industry Prospects Look Bright

Vertex (VRTX) Non-Cystic Fibrosis Pipeline Boosts Stock This Year

Bayer (BAYRY) Stops Heart Drug Study Due to Lack of Efficacy

SpringWorks (SWTX) Falls Despite Positive Mirdametinib Study Data

AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer

Chemomab (CMMB) Up on Fast Track Designation to CM-101 for PSC

CRISPR (CRSP), Vertex Get UK Nod for First Gene Therapy Casgevy

Bristol Myers (BMY) Receives FDA Approval for NSCLC Drug

Rocket (RCKT) Surges 40% in 3 Months on Regulatory Updates

Intellia (NTLA) Rises on EC's Orphan Drug Tag for HAE Candidate

DVAX과 유사한 종목